<DOC>
	<DOCNO>NCT00004234</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Giving radiation therapy different time day may affect chance develop side effect mucositis . PURPOSE : Randomized phase III trial compare incidence mucositis patient cancer mouth , pharynx , larynx , receive radiation therapy either morning afternoon .</brief_summary>
	<brief_title>Oral Mucositis Patients Receiving Radiation Therapy Cancer Mouth , Pharynx , Larynx</brief_title>
	<detailed_description>OBJECTIVES : - Compare toxicity radiotherapy oral mucosa deliver morning late afternoon patient squamous cell carcinoma oral cavity , pharynx ( oro/hypo/naso ) , larynx receive radiation treatment significant part oral and/or oropharyngeal mucosa . OUTLINE : This randomize , multicenter study . Patients stratify accord participate center , intend smoking behavior therapy ( smoke vs nonsmoking ) , plan total radiotherapy dose . Patients randomize receive radiotherapy daily , 5 day week , one two follow time day : - Arm I : Patients receive radiotherapy 8 10 AM ( local time ) . - Arm II : Patients receive radiotherapy 4 6 PM ( local time ) . Treatment continue 5-8 week , depend plan total radiotherapy dose , absence unacceptable toxicity disease progression . Toxicity assess baseline , first fraction radiotherapy , weekly treatment , weekly mucositis peak improving , every 2 week mucositis improve less grade 2 . Quality life assess baseline , weekly treatment toxicity peak improving , every 2 week toxicity less grade 2 mucositis , follow-up visit week 24 . Patients follow week 2-3 , 6-8 , 12 , 24 annually 3 year . PROJECTED ACCRUAL : A total 216 patient ( 108 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm squamous cell carcinoma oral cavity , pharynx ( oropharynx , hypopharynx , nasopharynx ) , larynx eligible radical radiotherapy TX , T14 , NX , N03 , M0 Directly visible area mucosa include 2 protocol specify anatomical location radical target volume At least 6 cm^2 area irrespective shape No M1 disease Intention deliver radiotherapy radical dose without chemotherapy May surgical resection primary neck node Postoperative macroscopic microscopic residual disease eligible radical radiotherapy allow Patients completely resect disease judge high risk relapse eligible radical radiotherapy allow PATIENT CHARACTERISTICS : Age : 16 Performance status : ECOG 01 Life expectancy : Not specify Hematopoietic : Hemoglobin ≥ 10 g/dL Granulocyte count ≥ 1,500/mm^3 Platelet count ≥ 100,000/mm^3 Hepatic : Not specify Renal : Not specify Other : Not pregnant nursing Fertile patient must use effective contraception HIV negative Must normal sleep habit ( i.e. , normal circadian rhythm ) Must dental assessment necessary prophylactic dental extraction carry No connective tissue disease ( e.g. , systemic lupus , scleroderma , mixed connective tissue disease , rheumatoid arthritis ) No organic brain syndrome related chronic alcohol excess cause sufficient severity would preclude cooperation treatment No active uncontrolled infection No history psychiatric neurological disorder would preclude study compliance PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics At least 6 month since prior chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior radiotherapy head neck region Surgery : See Disease Characteristics Other : No concurrent oral hygiene regimen describe protocol No concurrent radioprotective drug therapy</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>oral complication</keyword>
	<keyword>stage I squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage II squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage I squamous cell carcinoma oropharynx</keyword>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage I squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage II squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage I squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage II squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage I squamous cell carcinoma larynx</keyword>
	<keyword>stage II squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
</DOC>